Publications by authors named "Judith Greengard"

Claim this Profile
C
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.
Claire M Gelfman, Ruslan Grishanin, Kristina Oresic Bender, Aivan Nguyen, Judith Greengard

J Ocul Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates.
Szilárd Kiss, Kristina Oresic Bender, Ruslan N Grishanin, Kelly M Hanna, Julio D Nieves, Judith S Greengard

Transl Vis Sci Technol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.
Szilárd Kiss, Ruslan Grishanin, Aivan Nguyen, Romeo Rosario, Judith S Greengard

Mol Ther Methods Clin Dev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration.
Ruslan Grishanin, Brian Vuillemenot, Pallavi Sharma, Annahita Keravala, Judith Greengard

Mol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering goals for future thoracic endografts-how can we make them more effective?
Jenna M Weidman, Malhar Desai, Arif Iftekhar, Kevin Boyle, Judith S Greengard

Prog Cardiovasc Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis